Weightloss and Wellness

Pamela Bowen, Ph.D., addresses common myths about nutrition and provides practical insights into maintaining a healthy diet to prevent chronic diseases. 

UAB experts discuss the life cycle of the metabolism, ranging from before birth to older adulthood, and provide tips on metabolic health for a lifetime. 

UAB scientists discovered an oral drug stopped weight rebound after discontinuation or cessation of GLP‑1 treatment in preclinical studies, opening the door to a new approach for maintaining weight loss.

Since March 2022, UAB and McMaster University have advanced a shared vision to strengthen institutional collaboration across research, education and global health initiatives.

As UAB researchers continue to study how these drugs work and what comes next, their findings are helping move the conversation beyond hype, while working toward a clearer understanding of one of the most significant medical breakthroughs of the past decade.

Multisite research, including research at UAB, shows that oral semaglutide is nearly as effective as the widely used injectable version for treating obesity, delivering about 13.7 percent average weight loss over 64 weeks.

Researchers attribute this rise in exposures to an increase in prescriptions for these medications and an increase in therapeutic errors.

UAB is poised to lead the way in nutrition research and education, empowering students, professionals and community members to improve health outcomes through practical, evidence-based approaches.

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.